On November 5, 2020 the medicinal product was officially included in the List of Prequalified Medicinal Products by the World Health Organization (WHO)
Prequalification of medicinal products is a procedure performed by the WHO to assess the quality, safety and efficacy of medicinal products.
The inclusion of the medicinal product in the List of Prequalified Medicinal Products opens up opportunities for Farmak to participate in procurements conducted by international procurement organizations for the needs of the planet population.
Dexamethasone phosphate, except for its main area of intended use, was also included in the list of medicinal products used in the treatment of complications caused by COVID-19.
During the prequalification, the Company underwent the process from the product pharmaceutical development and registration dossier formation to inspection of manufacturing sites by WHO experts.
Quadcopters, cars, generators, medicines, and radio stations are just a part of the assistance provided by the Farmak company and the Zhebrivski Family Charitable Foundation of the Army. This support has been stable since 2014. Since the beginning of the full-scale war of the russian federation against Ukraine, it has grown even more and today […]
On November 28, the capital of Belgium hosted the annual Kyiv Investment Forum, which is a platform for discussing the implementation of projects and attracting investments. This year, Kyiv’s post-war reconstruction is in the spotlight in three key aspects: resilience, innovation, and sustainable development. The capital of Ukraine is the center of the...
Farmak, the Ukrainian pharmaceutical market leader, has invested UAH 50 million in a modern wastewater treatment system at its plant in Kyiv, which was launched this fall. Even in times of war, the company adheres to its strategy of sustainability and environmental responsibility. For two years, the company has been carrying out the reconstruction of [&helli...